Casa Blanca announces an agreement between Johnson & Johnson and its competitor Merck to manufacture the vaccine of a dose against COVID-19

The President of the United States, Joe Biden, announce this March that the Merck pharmaceutical company assists Johnson & Johnson in the manufacture of the vaccine against the coronavirus of a single dose, in an unusual pact between competing forces that could win drastically increase the amount of money recently authorized by the Department of Food and Drug Administration (FDA), according to the officers of the White House.

The officials who work with The Washington Post low anonymous condition, dijeron que to start searching for United States Collaborators to launch a mayor’s vacancy facility vacancy notary that notary Johnson & Johnson has retired in inoculation production. Quickly logging to find an agreement with Merck, one of the world’s largest car manufacturers, which has not logged in to unlock its own content against the coronavirus.

Following the agreement, Merck dedicates installations in the United States to Johnson & Johnson doses. A proportionate service of “llenado and acabado”, the ultimate stage of the production process during which the condition of the vaccine is collected in vials and packaged for distribution. The other makes the vaccine and has the potential to increase enormously the summit, quizzes including duplicating what Johnson & Johnson could do on its own, would leave the staff at The Washington Post.

“It is a historical association”, signaled one of them, at the time that aggregate that the companies “recognize that it was a war effort”, And praised the meaning of“ corporate citizenship ”.

Employees will not have to proportionate details about how Merck will influence the Johnson & Johnson project vacancy sum and the chronogram for distributors. A person familiar with the topic working with the media medium assured that you can ask for these ten to list the “llenado-acabado” plant and some more for equipping the other installation to unlock the car.

The efforts of the Biden administration to increase the production of the Johnson & Johnson vaccine suggest that it be considered the same play a very important game to get rid of the future challenges, as well as the possible need for inoculums for children and possibly refusal to counter the variants of coronavirus, said an acquaintance of the person who spoke to The Washington Post on condition of anonymity. Johnson & Johnson is making efforts to produce a dose dose that can be administered with different months, and no results have been hoped for in recent months.

Democrat administration officials indicate that Biden owns the powders of the Defense Production Ley, a 1950s era in the Korean War, for give priority to Merck in the safety of the teams that need to finish their installations for the production of vacancies, including the purchase of machinery, bolts, tubes and filtration systems.

Associate with Merck, Johnson & Johnson now have one allied with a tradition of a sail in the manufacture of vacancies. In the United States, Merck is the only provider of the infantile vaccine combined that protects against the sarampi, the papers and the rubella. También desarrolló Gardasil, which protects against human papillomavirus, and won the FDA approval for a vaccine against Ebola in 2019.

Without embarrassment, the company, which manufactures vacancies in North Carolina, Pennsylvania and other places, suffers contratiempos in his bus to unroll an inoculant against the coronavirus. The company announced the 25th of January that iba a detain the experimental dose doses against the coronavirus that the vaccine does not estimate to be sufficient to prevent phase 1 clinical trials in humans which justifies the continuation of the investigation.

Last Saturday, the FDA announced the vacancy emergency approval against Johnson & Johnson’s COVID-19 seal and is converted to the would like to distribute in United States, the most affected by the coronavirus pandemic, and the first a global level that only requires one dose. Its distinctive features and comparative sales are summarized in will have a single application and can be upgraded to a common refrigerator.

The proofs will show one 66% coronavirus efficacy, by 94-95% of existing vacancies, but with an 86% capacity to excavate serious cases of hospitalization, deaths and deaths, which can be sufficient to protect the population.

SEGUIR LEYENDO: